Thus, we treated PRP samples from hemorrhagic stroke patients with various platelet activators (ADP, TRAP-6, collagen, or AA) and exposed them to different doses of CDNF (0.1, 1, or 10 μg/mL). Here, CDNF is linked to hemorrhagic stroke.